Moreover, high expression of IL-6 led to over-expression of PD-L1 in CRPC cells, which, in turn, resulted in the death or inactivation of T cells and decreased expression of the NKG2D ligand, which disrupted NK cells in recognizing cancer cells. This evidence concerns the gene IL6 and cancer.